𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate

✍ Scribed by Koichiro Akakura; Susumu Akimoto; Takemasa Ohki; Jun Shimazaki

Book ID
119487756
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
628 KB
Volume
45
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Simultaneous antiandrogen withdrawal and
Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma
✍ Eric J. Small; Ari Baron; Robert Bok πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 66 KB

drawal and simultaneous ketoconazole as a means of inhibiting adrenal steroid production. Prostate specific antigen (PSA) response was defined as a ΓΊ 50% fall in PSA from baseline that was maintained for at least 8 weeks. ## RESULTS. Ten patients had established metastatic disease, 2 had high PSA

Codon 877 Mutation in the Androgen Recep
Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancer: Relation to Antiandrogen Withdrawal Syndrome
✍ Hiroyoshi Suzuki; Koichiro Akakura; Akira Komiya; Sara Aida; Susumu Akimoto; Jun πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

The growth of prostate cancer is androgen responsive, and androgen receptor (AR) is thought to play an important role in the development of this cancer. Recently, some reports demonstrated that AR gene mutations were detected in human prostate cancer tissues. We have previously reported that one of